Janssen-Cilag Ltd.
3 clinical trials · 3 recruiting · INDUSTRY
Trials by Janssen-Cilag Ltd.
RECRUITINGPhase 3NCT06408935
Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients
The purpose of this study is to evaluate the efficacy of guselkumab in healing of all layers of the digestive tract (transmural healing) with the help of a score called Magnetic...
Sponsor: Janssen-Cilag Ltd.Enrolling: 11220 locations
Crohn's Disease
RECRUITINGNCT07242248
A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's...
The purpose of this study is to evaluate the clinical effectiveness (how well the treatment works) of Guselkumab, by lines of treatment and subpopulations, and what are the...
Sponsor: Janssen-Cilag Ltd.Enrolling: 2201 location
Inflammatory Bowel DiseaseColitis, UlcerativeCrohn's Disease
RECRUITINGNCT07449234
A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
The purpose of this study is to assess the effectiveness and safety of guselkumab following a switch from ustekinumab or an ustekinumab biosimilar in participants with moderate to...
Sponsor: Janssen-Cilag Ltd.Enrolling: 2001 location
Psoriasis